Syndrome News and Research

RSS

Coronavirus is not mutating rapidly, hope for vaccine development

Despite the coronavirus infection numbers skyrocketing, there is still good news. A team of scientists found that the novel coronavirus is not mutating significantly, suggesting any vaccine developed to fight SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) would remain effective in the long term.

25 Mar 2020

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.

25 Mar 2020

Social distancing could stop coronavirus in just 13 weeks

The coronavirus disease (COVID-19) global pandemic has rippled across the world, with nearly 423,000 people now infected. Many countries have imposed lockdowns and strict quarantine measures to prevent the spread of the deadly virus.

25 Mar 2020

New test to measure expressive language skills of people with Fragile X syndrome

Researchers have developed a test to measure the expressive language skills of people with Fragile X syndrome, a genetic disorder that may result in intellectual disability, cognitive impairment and symptoms of autism spectrum disorder.

25 Mar 2020

German scientists test TB vaccine against coronavirus

The coronavirus disease (COVID-19) had taken a toll on the world, affecting 168 countries and more than 417,000 people. So far, more than 18,600 people have died due to complications of the disease. Scientists across the globe race to develop the first vaccine against the novel coronavirus.

24 Mar 2020

ELS can be useful in measuring outcomes for treatment studies in intellectual disabilities

A multi-university team of researchers found that expressive language sampling can be useful in measuring outcomes in clinical trials targeting fragile X syndrome.

24 Mar 2020

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

The U.K. government backs six projects aimed to fight the coronavirus outbreak, promising $23 million (£20 million) in funding. The projects, including two focused on vaccination trials, will help fast track the development of a vaccine to stop the spread of the coronavirus, leading to the death of more than 16,500 people across the globe.

24 Mar 2020

Huge WHO trial of COVID-19 therapies begins

As the world reels from the devastating impact and the looming threat of the novel coronavirus COVID-19, researchers around the globe are racing to find a cure that will reduce symptom severity and reverse the course of the disease, freeing up more hospital space and making it possible to treat more of the severely affected cases.

24 Mar 2020

Fatty acid-binding protein 4 plays an important role in kidney stone formation

Kidney stone disease has a high prevalence worldwide, ranging up to 13% in North America, 9% in Europe, and 5% in Asia. They are painful for patients, often lead to surgery, and impart a significant economic impact.

23 Mar 2020

Melinjo seed extract may improve obesity and diabetes

In Southeast Asia, the fruit, flowers, and leaves of Indonesia's "Melinjo" tree are traditional foods.

23 Mar 2020

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19.

23 Mar 2020

Lockdowns not enough to combat coronavirus, WHO warns

With more than 336,000 confirmed cases and at least 14,600 deaths across the globe, many countries and regions have imposed lockdowns in their territories to stem the spread of the coronavirus. The World Health Organization (WHO), however, says it is not enough.

23 Mar 2020

New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries

It is now abundantly clear that COVID-19 is not "just the flu" as Italy grapples to contain the virus. The country has taken surpassed the death toll of China since it recorded 5,476 deaths with a fatality rate of 8.3 percent. China has first shown a fatality rate of 2 to 3.4 percent, but a new study shows that the rate is lower than previously known.

22 Mar 2020

A review of the literature on acute promyelocytic leukemia

Oncotarget Volume 11, Issue 11 reported that relapsed APL, particularly in the high-risk subset of patients, remains an important clinical problem.

22 Mar 2020

Neuroscientists investigate how the brain controls the voice

Bats are famous for their sonar-based navigation. They use their extremely sensitive hearing for orientation, emitting ultrasound noises and receiving an image of their surroundings based on the echo.

22 Mar 2020

MILabs enhances preclinical diagnostic U-CT system for COVID-19 research

Based on recent scientific research, diagnostic X-ray CT is able to detect COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2), in individuals with high clinical suspicion of the virus -- even in cases with negative initial DNA tests.

20 Mar 2020

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

For decades, public health officials have directed the containment of emerging pandemics - perhaps most notably - the worldwide eradication of smallpox starting in the early to mid-1960s.

19 Mar 2020

Pets, the novel coronavirus and COVID-19 disease

Can dogs and other pets play a role in the transmission of the novel coronavirus? The question has surfaced after a Pomeranian in Hong Kong tested positive for the SARS-CoV-2 or the novel coronavirus last week.

19 Mar 2020

Lopinavir and ritonavir drug combo tested in severe COVID-19

Researchers from China and the United Kingdom have collaborated to conduct a clinical trial looking at the efficacy of a combination of two anti-HIV drugs lopinavir and ritonavir to combat severe cases of COVID-19. Their study titled, “A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19,” was published in the latest issue of the New England Journal of Medicine (NEJM).

19 Mar 2020